Cargando…

Screening for Anxiety and Depressive Symptoms in Type 2 Diabetes Using Patient-Reported Outcome Measures: Comparative Performance of the EQ-5D-5L and SF-12v2

Objective. To evaluate the performance of EQ-5D-5L (EuroQol Five-Dimension, Five-Level Questionnaire) and SF-12-v2 (12-item Medical Outcomes Health Survey–Short Form, Version 2) in screening for anxiety and depressive symptoms in adults with type 2 diabetes. Methods. Cross-sectional data from a popu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Sayah, Fatima, Ohinmaa, Arto, Johnson, Jeffrey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855395/ https://www.ncbi.nlm.nih.gov/pubmed/35187242 http://dx.doi.org/10.1177/2381468318799361

Ejemplares similares

The performance of the EQ-5D-3L in screening for anxiety and depressive symptoms in hospital and community settings
por: Short, Hilary, et al.
Publicado: (2021)

Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis
por: Tawiah, Andrews K., et al.
Publicado: (2019)

Comparative performance of the EuroQol EQ-5D-5L and the CDC healthy days measures in assessing population health
por: Derkach, Maryna, et al.
Publicado: (2022)

The use of EQ-5D-5L as a patient-reported outcome measure in evaluating community rehabilitation services in Alberta, Canada
por: Short, Hilary, et al.
Publicado: (2023)

Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients
por: Tran, Bach Xuan, et al.
Publicado: (2012)

A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada
por: Xie, Feng, et al.
Publicado: (2016)

Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
por: Gabbe, Belinda J, et al.
Publicado: (2015)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation Study
por: Al Shabasy, Sahar, et al.
Publicado: (2022)

Implementation of EQ-5D-5L as a routine outcome measure in Community Outpatient and Specialized Rehabilitation Services
por: Churchill, Katie, et al.
Publicado: (2021)

Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D
por: Stolz, Maike, et al.
Publicado: (2022)

Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression
por: Abdin, Edimansyah, et al.
Publicado: (2021)

An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
por: Dritsaki, Melina, et al.
Publicado: (2017)

Examining the psychometric properties of a split version of the EQ-5D-5L anxiety/depression dimension in patients with anxiety and/or depression
por: Belay, Yared Belete, et al.
Publicado: (2023)

A multi-level approach for the use of routinely collected patient-reported outcome measures (PROMs) data in healthcare systems
por: Al Sayah, Fatima, et al.
Publicado: (2021)

Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey
por: Xie, Shitong, et al.
Publicado: (2022)

Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China
por: Xie, Shitong, et al.
Publicado: (2023)

The impact of COVID-19 pandemic on health-related quality of life of adults visiting emergency departments and primary care settings in Alberta
por: Al Sayah, Fatima, et al.
Publicado: (2022)

Self-reported health-related quality of life of the general population in Alberta, Canada during the COVID-19 pandemic
por: Wen, Jiabi, et al.
Publicado: (2022)

Health-related quality of life in pregnant women living with HIV: a comparison of EQ-5D and SF-12
por: Wang, Xiaowen, et al.
Publicado: (2017)

The relationship between individual-level deprivation and health-related quality of life
por: Kashem, Tahmid, et al.
Publicado: (2019)

Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
por: van Stel, Henk F, et al.
Publicado: (2006)

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
por: Rowen, Donna, et al.
Publicado: (2009)

Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
por: Yousefi, Mahmood, et al.
Publicado: (2016)

Psychometric performance of EQ-5D-5L and SF-6DV2 in measuring health status of populations in Chinese university staff and students
por: Zhou, Hui Jun, et al.
Publicado: (2023)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ
por: Menn, Petra, et al.
Publicado: (2010)

Responsiveness to change in health status of the EQ-5D in patients treated for depression and anxiety
por: Sandin, Kenneth, et al.
Publicado: (2023)

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
por: Harrison, M. J., et al.
Publicado: (2009)

A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach
por: Kontodimopoulos, Nikolaos, et al.
Publicado: (2022)

A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain
por: Ye, Ziping, et al.
Publicado: (2019)

Assessment of Quality of Life in Patients With Cardiovascular Disease Using the SF-36, MacNew, and EQ-5D-5L Questionnaires
por: Chatzinikolaou, Aikaterini, et al.
Publicado: (2021)

Psychometric assessment of EQ-5D-5L and ReQoL measures in patients with anxiety and depression: construct validity and responsiveness
por: Franklin, Matthew, et al.
Publicado: (2021)

Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
por: Olariu, Elena, et al.
Publicado: (2023)

EQ-5D-5L and SF-6Dv2 utility scores in people living with chronic low back pain: a survey from Quebec
por: Poder, Thomas G, et al.
Publicado: (2020)

The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes
por: Mulhern, Brendan, et al.
Publicado: (2014)

Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke
por: Kim, Sang-Kyu, et al.
Publicado: (2015)

Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
por: Abdin, Edimansyah, et al.
Publicado: (2018)

Health status of the advanced elderly in six european countries: results from a representative survey using EQ-5D and SF-12
por: König, Hans-Helmut, et al.
Publicado: (2010)

Estimating the disutility of relapse in relapsing–remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models
por: Ahmad, Hasnat, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rric70rhta0d30vk68jp2l7bv1